IDDO team members will participate in a variety of sessions and symposia. These take place alongside other oral and poster presentations that come under the WWARN malaria research.
In Scientific Session 41, IDDO Director Prof Philippe Guérin will discuss the latest partnership between IDDO and the Drugs for Neglected Diseases Initiative (DNDi) in planning and delivering a visceral leishmaniasis (VL) data platform. This platform will maximise the utility of existing resources and enable researchers to address priority questions in VL treatment within a framework that recognises the contributions of data contributors and clinical trial participants.
Monday 6 November, 3:15 - 3:30 PM
Session 41 - Kinetoplastida: Diagnosis, Treatment and Vaccine Development
Convention Center - Room 337/338 (Level 300)
A symposium on substandard and falsified medicines will be co-chaired by IDDO’s Head of Medicine Quality, Prof Paul Newton. This symposium will highlight some of the global initiatives underway related to the development and evaluation of existing and emerging screening technologies and discuss the future of these valuable and constantly evolving tools. IDDO’s Medicine Quality Scientific Coordinator, Dr Céline Caillet will present her own research into device use in pharmacy settings.
Thursday 9 November 9, 8:00 - 9:45 AM
Session 181 - Lasers, Rays and Dyes: Tools and Initiatives in the Fight against Substandard and Falsified Medicines
Convention Center - Room 327/328/329 (Level 300)
Co-Chair: Paul Newton
We will also have a meeting room, so please contact us to arrange a side meeting during the conference. The meeting room is located in the Hilton - Tubman AB (West Building, Third Floor) - located across the street and connected by walkway to the Baltimore Convention Center.